0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Stage
Employees
Links
View full screen
Hugh Y. Rienhoff, Jr.
View all
5 members
Kymera Therapeutics
3 followers
Cartesian Therapeutics
1 follower
Tempus Labs
12 followers
Ultragenyx Pharmaceutical
5 followers
Biogen
92 followers
Explore more companies